
|Videos|October 6, 2017
Dr. De Santis on the Future Treatment Landscape for Bladder Cancer
Author(s)Maria De Santis, MD
Maria De Santis, MD, associate clinical professor at the University of Warwick, discusses the future treatment landscape for patients with bladder cancer.
Advertisement
Maria De Santis, MD, associate clinical professor at the University of Warwick, discusses the future treatment landscape for patients with bladder cancer.
In the future, we should differentiate between surgery, radiotherapy, and medical oncology, states De Santis.
There has been an improvement in overall survival in the second-line treatment compared to chemotherapy, and this field will expand further with new studies evaluating combinations of immunotherapy and combinations of chemotherapy with immunotherapy, as well.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
HPV Vaccination and Evolving Screening Strategies Continue to Shape Cervical Cancer Prevention Efforts
3
The OncFive: Top Oncology Articles for the Week of 1/25
4
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
5


































